![Mouse-Derived Isograft (MDI) In Vivo Tumor Models I. Spontaneous sMDI Models: Characterization and Cancer Therapeutic Approaches. Cancers, 2019](https://www.reactionbiology.com/wp-content/uploads/2023/07/sMDI_Cancers_including-supplements.png)
![Mouse-Derived Isograft (MDI) In Vivo Tumor Models I. Spontaneous sMDI Models: Characterization and Cancer Therapeutic Approaches. Cancers, 2019](https://www.reactionbiology.com/wp-content/uploads/2023/07/sMDI_Cancers_including-supplements.png)
![Mouse-Derived Isograft (MDI) In Vivo Tumor Models II. Carcinogen-Induced cMDI Models: Characterization and Cancer Therapeutic Approaches. Cancers, 2019](https://www.reactionbiology.com/wp-content/uploads/2023/07/cMDI_Cancers_including-supplements.png)
Mouse-Derived Isograft (MDI) In Vivo Tumor Models II. Carcinogen-Induced cMDI Models: Characterization and Cancer Therapeutic Approaches. Cancers, 2019
![In Vivo Pharmacology Brochure](https://www.reactionbiology.com/wp-content/uploads/2023/07/InVivo_Brochure_thumbnail.png)
In Vivo Pharmacology Brochure
![New spontaneous and carcinogen-induced mouse-derived isograft (MDI) tumor models for immune therapeutic approaches](https://www.reactionbiology.com/wp-content/uploads/2023/07/MDI_Poster_1.png)
New spontaneous and carcinogen-induced mouse-derived isograft (MDI) tumor models for immune therapeutic approaches
![All-in-one flow cytometry staining panel for immune-cell profiling in syngeneic tumor models](https://www.reactionbiology.com/wp-content/uploads/2023/07/poster-thumbnail_0.png)